, Tracking Stock Market Picks
Enter Symbol:
Biomimetic Therapeutics, Inc. (BMTI) [hlAlert]

down 16.46 %

Biomimetic Therapeutics, Inc. (BMTI) rated Buy with price target $24 by Canaccord Adams

Posted on: Wednesday,  Oct 14, 2009  8:25 AM ET by Canaccord Adams

Canaccord Adams rated Buy Biomimetic Therapeutics, Inc. (NASDAQ: BMTI) on 10/14/2009. Previously Canaccord Adams rated Buy Biomimetic Therapeutics, Inc. (NASDAQ: BMTI) on
11/14/2007., when the stock price was $11.36. Since then, Biomimetic Therapeutics, Inc. has lost 16.46% as of 02/28/2013's recent price of $9.49.
If you would have followed the previous Canaccord Adams's recommendation on BMTI, you would have lost 16.46% of your investment in 1933 days.

BioMimetic Therapeutics, Inc. (BioMimetic) develops and commercializes products to stimulate the body?s natural tissue regenerative process. The Company?s protein therapeutic-device combination products are used for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage. The Company?s platform regenerative technology, which incorporates a potent version of one of the body?s natural key stimulators of tissue repair, may offer physicians advanced biological solutions to actively stimulate tissue healing and regeneration. The Company focuses on developing GEM 21S technology to stimulate tissue healing in orthopedic applications (such as distal radius, or wrist, fractures and fusions of the bones in the foot and ankle to eliminate chronic pain from trauma or arthritis), and potentially spine and sports injury applications.

Canaccord Adams provides focused, actionable, idea-driven research, helping clients make informed investment decisions. Our 55 international analysts scour the globe for emerging and small to mid cap (US$1-2 billion market capitalization) growth opportunities, identifying value and exposing risk. Our research team analyzes over 550 companies in eight sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Our clients benefit from our thorough and sophisticated knowledge of the sectors we cover - Metals and Mining, Energy, Technology, Life Sciences, Real Estate, Consumer, Sustainability and Industrial Growth. We combine independent, actionable ideas, unique global perspective and unparalleled industry expertise. We believe it's evident in our research, and the foundation of our business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/14/2009 8:25 AM Buy
14.79 24.00
as of 12/31/2009
1 Week up  16.59 %
1 Month up  27.32 %
3 Months up  11.05 %
1 YTD up  47.07 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/11/2008 11:25 AM Buy
8.15 10.50
3/13/2008 12:25 PM Buy
13.50 19.00
11/14/2007 1:25 PM Buy
11.36 20.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy